Category: Healthcare
Industry: Drug Manufacturers - Major Quick infos Headquarters: Cambridge, United Kingdom Trade prices Volume: Market Cap: 100.47B Prev closed: 7701 Open: 7675 High: 7712 Low: 7621 52 week low: 5312 52 week high: 7948 Dividends: Next ER: February 2, 2018 After Market Closes
About the Company AstraZeneca plc is an AngloâSwedish multinational pharmaceutical and biopharmaceutical company. In 2013, it moved its headquarters to Cambridge, UK, and concentrated its R&D in three sites: Cambridge; Gaithersburg, Maryland, USA (location of MedImmune) for work on biopharmaceuticals; and Mölndal (near Gothenburg) in Sweden, for research on traditional chemical drugs. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.
Earnings History Date EPS / Forecast Revenue / Forecast November 8, 2018 - / 0.68- / 5,147MJuly 26, 2018 0.53 / 0.715.16B / 4,822MMay 18, 2018 0.36 / 0.605.18B / 5,283MFebruary 2, 2018 0.96 / 0.845.78B / 5,473MNovember 9, 2017 0.79 / 1.076.23B / 5,972Mview more
Historical Data Date Price Open High Low Vol Change ER Dec 10, 2021 8,193.0 8,280.0 8,332.0
8,122.0
1.68M -2.02% Dec 9, 2021 8,362.0 8,386.0 8,411.0
8,306.0
1.60M 0.94% Dec 8, 2021 8,284.0 8,300.0 8,364.0
8,229.0
1.87M 0.74% Dec 7, 2021 8,223.0 8,277.0 8,320.0
8,090.3
2.27M -1.67% Dec 6, 2021 8,363.0 8,212.0 8,431.0
8,201.9
1.32M 2.10% Dec 3, 2021 8,191.0 8,250.0 8,269.6
8,098.0
1.63M -0.49% Dec 2, 2021 8,231.0 8,306.0 8,347.0
8,213.0
1.82M -1% Dec 1, 2021 8,314.0 8,303.0 8,374.0
8,232.0
1.93M 0.46% Nov 30, 2021 8,276.0 8,262.0 8,334.0
8,151.0
3.72M -1.09% Nov 29, 2021 8,367.0 8,386.0 8,437.0
8,280.0
2.31M -0.52% view more
LON
More profiles and info about the company Founded:6 April 1999 Employees:59,700 News
Shore Capital Reiterates “Buy” Rating for AstraZeneca (LON ... rivertonroll.com Jan 23, 2020 11:52 am
AstraZeneca (LON:AZN) Given a GBX 6000 Price Target at ... rivertonroll.com Jan 23, 2020 10:52 am
AstraZeneca (LON:AZN) Earns Buy Rating from Shore Capital techknowbits.com Jan 23, 2020 9:52 am
Barclays Boosts AstraZeneca (LON:AZN) Price Target to GBX ... rivertonroll.com Jan 23, 2020 9:52 am
AstraZeneca (LON:AZN) Price Target Increased to GBX 8100 ... techknowbits.com Jan 22, 2020
AstraZeneca (LON:AZN) PT Raised to GBX 8500 slatersentinel.com Jan 22, 2020
Liberum Capital Boosts AstraZeneca (LON:AZN) Price Target ... techknowbits.com Jan 21, 2020
AstraZeneca (LON:AZN) Price Target Raised to GBX 8500 slatersentinel.com Jan 19, 2020 Is AstraZeneca Stock Worth Buying Before Earnings? - Investorplace.com investorplace.com Apr 10, 2019 8:04 pm Myriad expands partnership with AstraZeneca and Merck - Myriad Genetics, Inc. (NASDAQ:MYGN) - Seeking Alpha seekingalpha.com Apr 4, 2019 8:04 am
Fitch Says AstraZeneca Financial Outlook Improved... - Morningstar morningstar.co.uk Apr 3, 2019 8:04 am
AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion finance.yahoo.com Apr 2, 2019 9:04 pm
AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion - Barron's barrons.com Apr 2, 2019 9:04 pm
AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation (NYSE:AZN) - Benzinga benzinga.com Apr 1, 2019 7:04 pm AstraZeneca News: Why AZN Stock Is Sliding Lower Today - Investorplace.com investorplace.com Mar 30, 2019 7:03 pm
European stocks rise, clocking best quarter in four years finance.yahoo.com Mar 29, 2019 7:03 pm
AstraZeneca Will Pay Up to $6.9 Billion for Rights to Japanese Drugmaker's Cancer Drug - Fortune fortune.com Mar 29, 2019 7:03 pm
AstraZeneca Pays $6.9 Billion to Jointly Develop Cancer Drug - Bloomberg bloomberg.com Mar 29, 2019 7:03 pm
Mondelez may be shopping, AstraZeneca makes major deal, Tim Cook may testify - Yahoo Finance finance.yahoo.com Mar 29, 2019 7:03 pm
AstraZeneca Bets $6.9 Billion in Japan Cancer Therapy Deal - Bloomberg bloomberg.com Mar 29, 2019 8:03 am AZN.L Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Aug 13, 2020 218.3 Sep 14, 2020 Feb 27, 2020 218.7 Mar 30, 2020 Aug 8, 2019 218.7 Sep 9, 2019 Feb 28, 2019 215.2 Mar 27, 2019 Aug 9, 2018 202 Sep 10, 2018 view more
Key Persons CEO : Pascal Soriot, PhD, MBA Talk about AstraZeneca below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet